A Dayton-area medical technology firm has recently had its AI-driven image processing and analysis technology cleared by the ...

Recent federal developments may soon require cosmetic companies to adopt stringent precautions to ensure that talc-containing ...

Immix Biopharma (IMMX) announced that the U.S. FDA has granted RMAT designation to sterically-optimized CAR-T NXC-201 for the treatment of ...

Therapeutics announced that the U.S. FDA has granted Fast Track designation for rezpegaldesleukin for the treatment of adult and ...

Penn State Extension will offer a course to help produce growers meet food safety rules as outlined in the Food Safety Modernization Act, also known as FSMA, administered by the U.S. Food and Drug ...

AIHBA is constantly working to give beauty and wellness entrepreneurs an edge. That’s why it recently upgraded its membership ...

Not all chemical hair relaxers include the chemical, but many include ingredients that can release formaldehyde when heated, the FDA said in 2024. Over the years, an increasing number of studies ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Cortland, New York – Cortland Biomedical, a full-service biomedical textile product development partner that provides access to a full spectrum of global engineering, design, and manufacturing ...

Jan 21 (Reuters) - The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's (JNJ.N), opens new tab nasal spray, Spravato, to allow it to be used as a standalone treatment ...